Bionomics Limited Appoints Aaron Weaver as Non-Executive Director to the Board of Bionomics Limited from 6 July 2020
July 02, 2020 at 07:57 pm
Bionomics Limited announced that Mr. Aaron Weaver has been appointed as a Non-Executive Director to the Board of Bionomics Limited from 6 July 2020. Mr. Weaver is a Managing Director at Apeiron Investments focused on the life sciences sector. He also serves as Senior General Counsel and supports fundraising and investor relations activities at
ATAI Life Sciences AG, a clinical stage biopharmaceutical company focused on the development of therapeutics for the treatment of mood disorders, addiction and anxiety. He is a Chartered Financial Analyst (CFA) and a registered solicitor in the United Kingdom. From 2013 2017, he was an investment banker at Credit Suisse in London within the Capital Markets Solutions team, advising on capital structuring and issuances for a full spectrum of corporate issuers from pre-revenue companies to public listed companies.